Phase II study of sorafenib in co... preview & related info | MendeleyPhase II study of sorafenib in co... preview & related info | Mendeley

PURPOSE: The combination of sorafenib with chemotherapy is well-tolerated and is associated with encouraging response rates in ... Antineoplastic Combined Chemotherapy Protocols. *Antineoplastic Combined Chemotherapy Protocols: th. *Benzenesulfonates. * ... A phase II study was conducted to determine the efficacy and toxicity of combined sorafenib, docetaxel, and cisplatin in ... PURPOSE: The combination of sorafenib with chemotherapy is well-tolerated and is associated with encouraging response rates in ...
more infohttps://www.mendeley.com/research-papers/phase-ii-study-sorafenib-combination-docetaxel-cisplatin-treatment-metastatic-advanced-gastric-gastr/

Search of: nabilone OR cesamet AND Antiemetics - List Results - ClinicalTrials.govSearch of: nabilone OR cesamet AND Antiemetics - List Results - ClinicalTrials.gov

Antineoplastic Combined Chemotherapy Protocols. *Drug: Cesamet™ (nabilone). Interventional. Phase 4. *NEMA Research, Inc. ... A Phase IV Trial of Cesamet™ Given With Standard Antiemetic Therapy for Chemotherapy-induced Nausea and Vomiting. *Nausea and ... Evaluation of the Efficacy of Cesamet™ for the Treatment of Pain in Patients With Chemotherapy-Induced Neuropathy. *Peripheral ... To demonstrate incremental improvement with Cesamet in control of chemotherapy induced nausea and vomiting in patients who have ...
more infohttps://clinicaltrials.gov/ct2/results?term=nabilone+OR+cesamet+AND+Antiemetics

Effect of Chemotherapy With Paclitaxel/Cisplatin on Development Dysgeusia in Non Small Cell Lung Cancer - Full Text View -...Effect of Chemotherapy With Paclitaxel/Cisplatin on Development Dysgeusia in Non Small Cell Lung Cancer - Full Text View -...

Antineoplastic Combined Chemotherapy Protocols. Paclitaxel. Cisplatin. Additional relevant MeSH terms: Lung Neoplasms. ... Antineoplastic Agents, Phytogenic. Antineoplastic Agents. Tubulin Modulators. Antimitotic Agents. Mitosis Modulators. Molecular ... Effect of Chemotherapy With Paclitaxel/Cisplatin on Development Dysgeusia in Non Small Cell Lung Cancer. The safety and ... Effect of Chemotherapy With Paclitaxel and Cisplatin on Development Dysgeusia in Non-small Cell Lung Cancer Patients. ...
more infohttps://clinicaltrials.gov/ct2/show/NCT01540045

Antibody responses to Hepatitis B and measles-mumps-rubella vaccines in children who received chemotherapy for acute...Antibody responses to Hepatitis B and measles-mumps-rubella vaccines in children who received chemotherapy for acute...

Keywords : Leukemia, lymphoid; Antineoplastic combined chemotherapy protocols; Immunization; Viral vaccines; Child. · text in ... RESULTS: After chemotherapy, 75.9%, 67.9%, 59.3% and 51.7% of the patients showed low antibody titers that would be unlikely to ... OBJECTIVE: To evaluate viral vaccine antibody levels in children with acute lymphoblastic leukemia after chemotherapy and after ... Antibody responses to Hepatitis B and measles-mumps-rubella vaccines in children who received chemotherapy for acute ...
more infohttp://www.scielo.br/scielo.php?script=sci_abstract&pid=S1516-84842012000400011&lng=en&nrm=iso&tlng=en

A novel, small molecule inhibitor of Hsc70/Hsp70 potentiates Hsp90 inhibitor induced apoptosis in HCT116 colon carcinoma cells.A novel, small molecule inhibitor of Hsc70/Hsp70 potentiates Hsp90 inhibitor induced apoptosis in HCT116 colon carcinoma cells.

Antineoplastic Combined Chemotherapy Protocols / pharmacology. Apoptosis / drug effects*. Breast Neoplasms / drug therapy, ... Title: Cancer chemotherapy and pharmacology Volume: 66 ISSN: 1432-0843 ISO Abbreviation: Cancer Chemother. Pharmacol. ...
more infohttp://www.biomedsearch.com/nih/novel-small-molecule-inhibitor-potentiates/20012863.html

Insulin receptor substrate 1 expression enhances the sensitivity of 32D cells to chemotherapy-induced cell death.Insulin receptor substrate 1 expression enhances the sensitivity of 32D cells to chemotherapy-induced cell death.

Antineoplastic Combined Chemotherapy Protocols / pharmacology*. Cell Death / drug effects. Cells, Cultured. Dose-Response ... The role of IRS1 and IRS2 in controlling cell responses to chemotherapy is unknown. To determine the role of IRS1 and IRS2 in ... We found that expression of IRS1, in contrast to IRS2, enhanced the sensitivity of 32D cells to chemotherapy-induced apoptosis ... Decreasing Annexin A2 levels reduced 32D-IRS1 cell sensitivity to chemotherapy. These results suggest IRS1 enhances sensitivity ...
more infohttp://www.biomedsearch.com/nih/Insulin-receptor-substrate-1-expression/22652453.html

Program Members > Yale Cancer Center | Yale School of...Program Members > Yale Cancer Center | Yale School of...

Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Head and Neck Neoplasms ...
more infohttps://medicine.yale.edu/cancer/patient/programs/thoracic/members/

Program MembersProgram Members

Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Head and Neck Neoplasms ...
more infohttp://www.yalecancercenter.org/patient/programs/thoracic/members/

Study of Motexafin Gadolinium and Docetaxel for Advanced Solid TumorsStudy of Motexafin Gadolinium and Docetaxel for Advanced Solid Tumors

Antineoplastic Combined Chemotherapy Protocols. *Breast Neoplasms. *Neoplasms. *Lung Neoplasms. *Ovarian Neoplasms. *Prostatic ... Chemotherapy, radiation therapy, immunotherapy, or systemic biologic. - anticancer therapy within 21 days before beginning ... progressed during or after one or more chemotherapy regimens; Metastatic breast. cancer; Hormone-refractory prostate cancer; ...
more infohttp://www.knowcancer.com/cancer-trials/NCT00080041/

Dan-Arin Silasi, MD | Yale School of MedicineDan-Arin Silasi, MD | Yale School of Medicine

Antineoplastic Combined Chemotherapy Protocols. *Pelvic Exenteration. *Pelvic Neoplasms. *Chemotherapy, Cancer, Regional ... In Combination With And/or Following Chemotherapy In Patients With Previously Untreated Epithelial Ovarian Cancer ... or Primary Peritoneal Cancer That Have Received at Least 2 Prior Lines of Chemotherapy ... Versus Investigators Choice of Chemotherapy in Women With Folate Receptor Alpha Positive Advanced Epithelial Ovarian Cancer, ...
more infohttp://medicine.yale.edu/intranet/facultybydept/dan-arin_silasi-3.profile

Plus itPlus it

Antineoplastic combined chemotherapy protocols. With the important exception of the E4599 trial of bevacizumab in conjunction ... Trials combining cetuximab with chemotherapy have shown a trend to increased response rate and prolonged progression-free ... ATLAS is a phase III trial of bevacizumab with chemotherapy followed by erlotinib after chemotherapy is completed that will ... that combined novel agents with standard chemotherapy have produced disappointing or equivocal results. Many agents identified ...
more infohttp://clincancerres.aacrjournals.org/content/13/15/4583s

Brazilian experience using high dose sequential chemotherapy followed by autologous hematopoietic stem cell transplantation for...Brazilian experience using high dose sequential chemotherapy followed by autologous hematopoietic stem cell transplantation for...

Antineoplastic Combined Chemotherapy Protocols [administration & dosage]; Cyclophosphamide [administration & dosage]; ... DUARTE, Bruno Kosa Lino et al. Brazilian experience using high dose sequential chemotherapy followed by autologous ... Chemotherapy consisted of the sequential administration of high-dose cyclophosphamide (4 or 7 g/m2) and granulocyte-colony ... OBJECTIVE: To evaluate the use of high-dose sequential chemotherapy in a Brazilian population. METHODS: High-dose ...
more infohttp://www.scielo.br/scielo.php?script=sci_abstract&pid=S1516-84842011000600011&lng=pt&nrm=iso&tlng=en

Academic Programs Faculty -  Last Initial L - Wake Forest School of MedicineAcademic Programs Faculty - Last Initial L - Wake Forest School of Medicine

Lymphoma, Non-Hodgkin; Antineoplastic Combined Chemotherapy Protocols; Hemangiopericytoma; Meningioma; Antiretroviral Therapy, ... Peritoneal Neoplasms; Hyperthermia, Induced; Chemotherapy, Cancer, Regional Perfusion; Adenocarcinoma; Antineoplastic Combined ... Carcinoma, Lobular; Biopsy; Antineoplastic Agents; Breast Neoplasms; Chemoprevention Academic: 336-716-4316. Department: 336- ... Brain Neoplasms; Glioma; Glioblastoma; Central Nervous System Neoplasms; Antineoplastic Agents Academic: 336-716-9527. ...
more infohttp://www.wakehealth.edu/School/FacultySR.htm?st=L&li=L&ft=R

AVE8062 in Combination With Platinum-taxane Doublet in Advanced Solid TumorAVE8062 in Combination With Platinum-taxane Doublet in Advanced Solid Tumor

Antineoplastic Combined Chemotherapy Protocol. *Neoplasms. .map{width:100%;height:300px;margin-bottom:15px}. Name. Location. ... Concurrent treatment with any other anticancer therapy, including chemotherapy,. immunotherapy, radiotherapy (excluding ...
more infohttp://www.knowcancer.com/cancer-trials/NCT00719524/

Arsenic trioxide improves event-free and overall survival for adults with acute promyelocytic leukemia: North American Leukemia...Arsenic trioxide improves event-free and overall survival for adults with acute promyelocytic leukemia: North American Leukemia...

Antineoplastic Combined Chemotherapy Protocols (administration & dosage) *Arsenicals (administration & dosage) *Cytarabine ( ...
more infohttp://www.curehunter.com/public/pubmed20705755.do

Continuous hyperfractionated accelerated radiotherapy (CHART) in localized cancer of the esophagus. | CureHunterContinuous hyperfractionated accelerated radiotherapy (CHART) in localized cancer of the esophagus. | CureHunter

Antineoplastic Combined Chemotherapy Protocols (therapeutic use) *Cause of Death. *Cisplatin (administration & dosage) ...
more infohttp://www.curehunter.com/public/pubmed9212014.do

Kaplan-Meiers estimate of overall survival and event-f | Open-iKaplan-Meier's estimate of overall survival and event-f | Open-i

Antineoplastic Combined Chemotherapy Protocols/therapeutic use. *Child. *Cohort Studies. *Cyclin D1/metabolism ... The combined TP53/MIPI show significant (P = 0·006) separation between low and intermediate risk groups in relation to (G) OS ... The combined TP53/MIPI show significant (P = 0·006) separation between low and intermediate risk groups in relation to (G) OS ... The combined SOX11/MIPI improves separation between low and intermediate risk groups (although, P , 0·05) in relation to (E) OS ...
more infohttps://openi.nlm.nih.gov/detailedresult.php?img=PMC4282019_bjh0166-0098-f3&req=4

The miR-21-mediated program is modified by 5-fluorourac | Open-iThe miR-21-mediated program is modified by 5-fluorourac | Open-i

Antineoplastic Combined Chemotherapy Protocols/therapeutic use. *Blotting, Western. *Cell Line, Tumor. *Cell Proliferation/drug ... Taken together, our findings demonstrate that microRNA-21 is a chemotherapy responsive microRNA and can serve as a prognostic ... Taken together, our findings demonstrate that microRNA-21 is a chemotherapy responsive microRNA and can serve as a prognostic ... However, the utility of specific microRNAs in predicting the clinical benefit of chemotherapy has not been well-established. ...
more infohttps://openi.nlm.nih.gov/detailedresult.php?img=PMC4385853_oncotarget-06-2302-g005&req=4

Gefitinib or Carboplatin-Paclitaxel in Pulmonary Adenocarcinoma - PubMedGefitinib or Carboplatin-Paclitaxel in Pulmonary Adenocarcinoma - PubMed

Antineoplastic Combined Chemotherapy Protocols / therapeutic use *. Actions. * Search in PubMed * Search in MeSH ... Gefitinib or Chemotherapy for Non-Small-Cell Lung Cancer With Mutated EGFR M Maemondo et al. N Engl J Med 362 (25), 2380-8. ... Erlotinib Versus Standard Chemotherapy as First-Line Treatment for European Patients With Advanced EGFR Mutation-Positive Non- ...
more infohttps://pubmed.ncbi.nlm.nih.gov/19692680/

HKU Scholars Hub: Isolated lymph node T lymphoblastic transformation of chronic myeloid leukemia during interferon treatmentHKU Scholars Hub: Isolated lymph node T lymphoblastic transformation of chronic myeloid leukemia during interferon treatment

Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use. en_US. dc.subject.mesh. Bone Marrow - Pathology. en_US. ...
more infohttp://hub.hku.hk/handle/10722/162287

ʿ??  2018????  ??   - ?????? IJ ??ʿ?? 2018???? ?? - ?????? IJ ??

24.antineoplastic combined chemotherapy protocols 12 ƪ8.000%. 25.cell line 11 ƪ7.333% ...
more infohttp://blog.sciencenet.cn/home.php?mod=space&uid=280034&do=blog&id=1098872

adenocarcinoma of sigmoid colon disorder 2005:2010[pubdate] *count=100 - BioMedLib™ search engineadenocarcinoma of sigmoid colon disorder 2005:2010[pubdate] *count=100 - BioMedLib™ search engine

Antineoplastic Combined Chemotherapy Protocols. Combined Modality Therapy. Diagnosis, Differential. Fluorouracil. Humans. ... Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Lung Neoplasms / drug therapy. Lung Neoplasms / secondary. ... Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Disease Progression. Pelvic Exenteration. Sigmoid Neoplasms ... Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Liver Neoplasms / secondary. Lung Neoplasms / secondary. ...
more infohttp://www.bmlsearch.com/?kwr=adenocarcinoma+of+sigmoid+colon+disorder+2005:2010%5Bpubdate%5D&cxts=100&stmp=b0

b cll b cell chronic lymphocytic leukemia variant drug 2000:2010[pubdate] *count=100 - BioMedLib™ search engineb cll b cell chronic lymphocytic leukemia variant drug 2000:2010[pubdate] *count=100 - BioMedLib™ search engine

MeSH-major] Antineoplastic Agents / therapeutic use. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Lymphoma ... Antineoplastic Combined Chemotherapy Protocols. Cell Membrane / metabolism. Combined Modality Therapy. Glycoproteins / ... MeSH-major] Antibiotics, Antineoplastic / administration & dosage. Antineoplastic Combined Chemotherapy Protocols / ... MeSH-major] Antineoplastic Agents / pharmacology. Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy. Leukemia, Lymphocytic ...
more infohttp://www.bmlsearch.com/?kwr=b+cll+b+cell+chronic+lymphocytic+leukemia+variant+drug+2000:2010%5Bpubdate%5D&cxts=100&stmp=b1